[HTML][HTML] Cannabidiol: a potential new alternative for the treatment of anxiety, depression, and psychotic disorders

MS García-Gutiérrez, F Navarrete, A Gasparyan… - Biomolecules, 2020 - mdpi.com
The potential therapeutic use of some Cannabis sativa plant compounds has been attracting
great interest, especially for managing neuropsychiatric disorders due to the relative lack of …

Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies

DP Finn, S Haroutounian, AG Hohmann, E Krane… - Pain, 2021 - journals.lww.com
This narrative review represents an output from the International Association for the Study of
Pain's global task force on the use of cannabis, cannabinoids, and cannabis-based …

[HTML][HTML] Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems

J Moltke, C Hindocha - Journal of cannabis research, 2021 - Springer
Background Public and medical interest in cannabidiol (CBD) has been rising, and CBD is
now available from various sources. Research into the effects of low-dose CBD on outcomes …

[HTML][HTML] Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review

J Sarris, J Sinclair, D Karamacoska, M Davidson, J Firth - BMC psychiatry, 2020 - Springer
Background Medicinal cannabis has received increased research attention over recent
years due to loosening global regulatory changes. Medicinal cannabis has been reported to …

[HTML][HTML] Use of cannabidiol in the treatment of epilepsy: efficacy and security in clinical trials

S Silvestro, S Mammana, E Cavalli, P Bramanti… - Molecules, 2019 - mdpi.com
Cannabidiol (CBD) is one of the cannabinoids with non-psychotropic action, extracted from
Cannabis sativa. CBD is a terpenophenol and it has received a great scientific interest …

Cannabidiol (CBD) use in psychiatric disorders: A systematic review

S Bonaccorso, A Ricciardi, C Zangani, S Chiappini… - Neurotoxicology, 2019 - Elsevier
Abstract Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) are the most represented
phytocannabinoids in Cannabis sativa plants. However, CBD may present with a different …

[HTML][HTML] Cannabis and its secondary metabolites: their use as therapeutic drugs, toxicological aspects, and analytical determination

J Gonçalves, T Rosado, S Soares, AY Simão… - Medicines, 2019 - mdpi.com
Although the medicinal properties of Cannabis species have been known for centuries, the
interest on its main active secondary metabolites as therapeutic alternatives for several …

[HTML][HTML] Use of medicinal cannabis and synthetic cannabinoids in post-traumatic stress disorder (PTSD): a systematic review

L Orsolini, S Chiappini, U Volpe, D De Berardis… - Medicina, 2019 - mdpi.com
Background and Objectives: Post-traumatic stress disorder (PTSD) is a common psychiatric
disorder resulting from a traumatic event, is manifested through hyperarousal, anxiety …

Therapeutic efficacy of cannabidiol (CBD): a review of the evidence from clinical trials and human laboratory studies

DJ Sholler, L Schoene, TR Spindle - Current addiction reports, 2020 - Springer
Rigorous, controlled evidence for the therapeutic efficacy of CBD is lacking for many health
conditions. Possible concerns with the use of CBD as a therapeutic include the potential for …

Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeutics

AK Schlag, SE O'Sullivan, RR Zafar, DJ Nutt - Neuropharmacology, 2021 - Elsevier
Abstract Knowledge about the therapeutic potential of medical cannabis has greatly
improved over the past decade, with an ever-increasing range of developments in human …